Genovese Burford & Brothers Wealth & Retirement Plan Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-400	Closed	-$28K	–	452
2017 Q4	$28K	Hold	400	–	–	0.07%	121
2017 Q3	$26K	Hold	400	–	–	0.01%	196
2017 Q2	$25K	Hold	400	–	–	0.01%	193
2017 Q1	$24K	Hold	400	–	–	0.01%	213
2016 Q4	$23K	Hold	400	–	–	0.01%	231
2016 Q3	$24K	Hold	400	–	–	0.01%	219
2016 Q2	$25K	Sell	400 -687	-63%	-$43.2K	0.01%	196
2016 Q1	$65K	Buy	1,087 +687	+172%	+$42K	0.03%	109
2015 Q4	$28K	Buy	+400	New	+$28.4K	0.01%	167

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FSA

Financial Sense Advisors San Diego, California $493M AUM 50.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's PJP Position: Q1 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2018, closing a stake of 400 shares — an estimated $28K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in PJP in Q4 2015 and held it in 9 quarters. The position peaked at $65K in Q1 2016. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 400 Invesco Pharmaceuticals ETF shares in Q1 2018, an estimated $28K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and held it in 9 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Invesco Pharmaceuticals ETF position peaked at $65K in Q1 2016.
96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q1 2018, filed 25 Apr 2018.